Risk factors for relapse after reinduction treatment with rituximab in patients with antineutrophil cytoplasmic ...
Some trials show modest improvements in fasting glucose, lipids, or inflammatory markers, possibly via antioxidant or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results